Nunes TF, Tibana TK, Morais Neto R, Marchiori E. Interventional treatment of symptomatic giant hepatic hemangiomas: initial results of the use of a combined technique. Radiol Bras. 2021;54:418–9.

Article  PubMed  PubMed Central  Google Scholar 

Ghanaati H, Abrishami A, Hashem Zadeh A, Ghiasi M, Nasiri Toosi M, Jafarian A. Computed tomography fluoroscopy-guided percutaneous transhepatic bleomycin/ethiodized oil sclerotherapy for symptomatic giant hepatic hemangioma. J Vasc Interv Radiol. 2022;33(1342–1348):e1341.

Google Scholar 

Lin Z, Zhu X, Zhou J. Ultrasound-guided percutaneous sclerotherapy versus surgical resection in the treatment of large hepatic hemangiomas: a retrospective study. BMC Surg. 2022;22:130.

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Jia Y, Li S, Wang W, Wang Z, Wang Y, et al. Transarterial chemoembolization of giant liver haemangioma: a multi-center study with 836 cases. Cell Biochem Biophys. 2015;73:469–72.

Article  CAS  PubMed  Google Scholar 

Horbach SER, Rigter IM, Smitt JHS, Reekers JA, Spuls PI, van der Horst C. Intralesional bleomycin injections for vascular malformations: a systematic review and meta-analysis. Plast Reconstr Surg. 2016;137:244–56.

Article  CAS  PubMed  Google Scholar 

Ayoobi Yazdi N, Mehrabinejad MM, Dashti H, Pourghorban R, Nassiri Toosi M, Rokni Yazdi H. Percutaneous sclerotherapy with bleomycin and ethiodized oil: a promising treatment in symptomatic giant liver hemangioma. Radiology. 2021;301:464–71.

Article  PubMed  Google Scholar 

Cai Q, Qian TG, Zhao QY, Feng SY, Yang Q, Luo YC, et al. Percutaneous microwave ablation versus sclerotherapy for large hepatic hemangioma: a multi-center cohort study. Int J Hyperthermia. 2024;41:2285705.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Article  PubMed  PubMed Central  Google Scholar 

Bozkaya H, Cinar C, Besir FH, Parildar M, Oran I. Minimally invasive treatment of giant haemangiomas of the liver: embolisation with bleomycin. Cardiovasc Intervent Radiol. 2014;37:101–7.

Article  PubMed  Google Scholar 

Gunkan A, Elek A, Ohannesian VA, Mendes LL, Pehlivan UA, Fouad MEM, Shafeea MS, Loffroy R, Hannallah J, Woodhead G, Young S. Safety and effectiveness of image-guided therapies for giant hepatic hemangiomas: a systematic review and meta-analysis of 2,617 patients. J Vasc Interv Radiol. 2025;

Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the Cirse classification system. Cardiovasc Intervent Radiol. 2017;40:1141–6.

Article  CAS  PubMed  Google Scholar 

Kusbeci M, Elek A, Ozturk E, Bozkaya H, Cinar C, Parildar M, et al. Long-term outcomes of transarterial chemoembolization of giant liver hemangiomas with lipiodol-bleomycin emulsion. Cardiovasc Intervent Radiol. 2024;47:1506–14.

Article  PubMed  Google Scholar 

Yuan B, Zhang JL, Duan F, Wang MQ. Medium and long-term outcome of superselective transcatheter arterial embolization with lipiodol-bleomycin emulsion for giant hepatic hemangiomas: results in 241 patients. J Clin Med. 2022. https://doi.org/10.3390/jcm11164762.

Article  PubMed  PubMed Central  Google Scholar 

Kacala A, Dorochowicz M, Korbecki A, Sobanski M, Pula M, Patrzalek D, Janczak D, Guzinski M. Transarterial bleomycin-lipiodol chemoembolization for the treatment of giant hepatic hemangiomas: an assessment of effectiveness. Cancers (Basel). 2024;16.

Akhlaghpoor S, Torkian P, Golzarian J. Transarterial bleomycin-lipiodol embolization (B/LE) for symptomatic giant hepatic hemangioma. Cardiovasc Intervent Radiol. 2018;41:1674–82.

Article  PubMed  Google Scholar 

Shali F, Xiaoqiang T, Jian W, Li S. Selective hepatic artery embolization for the treatment of giant hepatic hemangioma: a report of 46 cases. World Chinese J Digestol. 2013;21:1925–30.

Article  Google Scholar 

Kirnap M, Boyvat F, Boyacioglu S, Hilmioglu F, Moray G, Haberal M. The effect of bleomycin embolization on symptomatic improvement and hemangioma size among patients with giant liver hemangiomas. Int J Surg Open. 2018;12:12–6.

Article  Google Scholar 

Li J, Zhang S, Ning C, Li G, Guo S. Efficacy of radiofrequency ablation vs. transcatheter arterial embolization for hepatic hemangiomas. Eur J Gastroenterol Hepatol. 2024;36:750–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Liu FY, Yuan HJ, Tian XM, Tang J, Ye T, et al. Therapeutic evaluation and management strategy of transarterial embolization for giant liver hemangiomas exceeding 10 cm in diameter. Cardiovasc Intervent Radiol. 2021;44:2005–7.

Article  PubMed  PubMed Central  Google Scholar 

Ozden I, Poyanli A, Onal Y, Demir AA, Hos G, Acunas B. Superselective transarterial chemoembolization as an alternative to surgery in symptomatic/enlarging liver hemangiomas. World J Surg. 2017;41:2796–803.

Article  PubMed  Google Scholar 

Shi Y, Song J, Ding M, Tang X, Wang Z, Chi J, et al. Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes. Int J Hyperthermia. 2020;37:938–43.

Article  PubMed  Google Scholar 

Sun JH, Nie CH, Zhang YL, Zhou GH, Ai J, Zhou TY, et al. Transcatheter arterial embolization alone for giant hepatic hemangioma. PLoS ONE. 2015;10:e0135158.

Article  PubMed  PubMed Central  Google Scholar 

Zeng Q, Li Y, Chen Y, Ouyang Y, He X, Zhang H. Gigantic cavernous hemangioma of the liver treated by intra-arterial embolization with pingyangmycin-lipiodol emulsion: a multi-center study. Cardiovasc Intervent Radiol. 2004;27:481–5.

Article  PubMed  Google Scholar 

Arafat S, Abdelmabood AA, Mohamed W, El-Tagy G, El-Swify A. Comparative study between bleomycin and ethanol-amine oleate sclerotherapy in management of pediatric maxillofacial venous malformations: a randomized clinical trial.

Liu F, Yu X, Liang P, Cheng Z, Han Z, Yu J. Ultrasonography-guided percutaneous microwave ablation for large hepatic cavernous haemangiomas. Int J Hyperthermia. 2018;34:1061–6.

Article  PubMed  Google Scholar